CatalystPit

BMRNBIOMARIN PHARMACEUTICAL INC

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $60.00 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$11.61B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-01 · Friberg Gregory R (EVP, Chief R&D Officer) · OTHER
  • 2026-09-14 · Plenge Robert M (Director) · OTHER
  • 2026-09-03 · Davis George Eric (EVP, Chief Legal Officer) · SELL
  • 2026-06-04 · CLARK IAN T (Director) · OTHER
  • 2026-06-04 · Ho Maykin (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders608
Shares held299,277,203
Value$14.14B
Percent of shares outstanding154.61%
As of quarter end2026-06-30
RECENT NEWS
  • BioMarin presents data on VOXZOGO in achondroplasia treatment
  • BMRN: BioMarin Appoints Cara Bauer as Chief People Officer
  • BioMarin releases five-year Phase 3 data for POMBILITI plus OPFOLDA
  • BioMarin Pharmaceutical presents at Morgan Stanley healthcare conference
  • BioMarin appoints Robert Plenge to board of directors
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
BIOMARIN PHARMACEUTICAL INC (BMRN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit